Adams Brian — SEC insider filings

SEC reporting owner CIK 1636994. 47 insider filings on record with FilingPulse; latest filed 2026-09-04.

Transaction summary — filings shown

Covers all 47 filings on record, filed 2020-12-15 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Relay Therapeutics, Inc. (RLAY)Chief Legal Officer44—40 legs · 150,755 sh · $2,016,62522
Kymera Therapeutics, Inc. (KYMR)Chief Legal Officer3—3 legs · 6,371 sh · $744,2974

Insider filings — Adams Brian

FiledFormIssuerReported transactionsSource
2026-09-044Kymera Therapeutics, Inc. (KYMR)Sale (S): 1,209 @ $115.55 · Sale (S): 3,025 @ $116.81 · Sale (S): 2,137 @ $117.57EDGAR
2026-03-044Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 4,125 @ $0 · Grant/award (A): 8,250 (derivative) @ $0EDGAR
2025-09-034Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 52,500 @ $0 · Grant/award (A): 105,000 (derivative) @ $0EDGAR
2025-07-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,637 @ $3.74 · Sale (S): 18,276 @ $3.68EDGAR
2025-04-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,644 @ $3.17 · Sale (S): 12,943 @ $3EDGAR
2025-03-314Relay Therapeutics, Inc. (RLAY)Sale (S): 298 @ $2.84EDGAR
2025-01-304Relay Therapeutics, Inc. (RLAY)Sale (S): 33,688 @ $4.63 · Grant/award (A): 139,141 @ $0 · Sale (S): 20,791 @ $4.42EDGAR
2025-01-144Relay Therapeutics, Inc. (RLAY)Grant/award (A): 275,000 (derivative) @ $0EDGAR
2024-12-314Relay Therapeutics, Inc. (RLAY)Sale (S): 299 @ $4.38EDGAR
2024-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,632 @ $6.06EDGAR
2024-10-014Relay Therapeutics, Inc. (RLAY)Sale (S): 295 @ $7.51EDGAR
2024-07-314Relay Therapeutics, Inc. (RLAY)Sale (S): 1,638 @ $8.85EDGAR
2024-07-014Relay Therapeutics, Inc. (RLAY)Sale (S): 295 @ $6.26EDGAR
2024-04-294Relay Therapeutics, Inc. (RLAY)Sale (S): 1,623 @ $6.38EDGAR
2024-03-294Relay Therapeutics, Inc. (RLAY)Sale (S): 348 @ $7.70EDGAR
2024-01-314Relay Therapeutics, Inc. (RLAY)Sale (S): 1,929 @ $9.64EDGAR
2024-01-184Relay Therapeutics, Inc. (RLAY)Grant/award (A): 200,000 @ $0EDGAR
2023-12-294Relay Therapeutics, Inc. (RLAY)Sale (S): 294 @ $11.51EDGAR
2023-11-014Relay Therapeutics, Inc. (RLAY)Sale (S): 1,632 @ $6.03EDGAR
2023-09-294Relay Therapeutics, Inc. (RLAY)Sale (S): 294 @ $8.38EDGAR
2023-07-314Relay Therapeutics, Inc. (RLAY)Sale (S): 1,628 @ $11.80EDGAR
2023-06-284Relay Therapeutics, Inc. (RLAY)Sale (S): 294 @ $12.12EDGAR
2023-06-014/ARelay Therapeutics, Inc. (RLAY)Sale (S): 1,936 @ $11.16EDGAR
2023-05-014Relay Therapeutics, Inc. (RLAY)Sale (S): 863 @ $11.16EDGAR
2023-03-284Relay Therapeutics, Inc. (RLAY)Sale (S): 347 @ $15.36EDGAR
2023-01-314Relay Therapeutics, Inc. (RLAY)Sale (S): 864 @ $21.56EDGAR
2023-01-194Relay Therapeutics, Inc. (RLAY)Grant/award (A): 85,425 @ $0 · Grant/award (A): 97,630 (derivative) @ $0 · Grant/award (A): 73,220 (derivative) @ $0EDGAR
2023-01-134Relay Therapeutics, Inc. (RLAY)Sale (S): 9,994 @ $20EDGAR
2022-12-284Relay Therapeutics, Inc. (RLAY)Sale (S): 295 @ $14.49EDGAR
2022-11-014Relay Therapeutics, Inc. (RLAY)Sale (S): 728 @ $21.54EDGAR
2022-09-294Relay Therapeutics, Inc. (RLAY)Sale (S): 294 @ $22.73EDGAR
2022-07-294Relay Therapeutics, Inc. (RLAY)Sale (S): 734 @ $21.27EDGAR
2022-06-284Relay Therapeutics, Inc. (RLAY)Sale (S): 300 @ $20.31EDGAR
2022-05-024Relay Therapeutics, Inc. (RLAY)Sale (S): 708 @ $25.57EDGAR
2022-03-314Relay Therapeutics, Inc. (RLAY)Sale (S): 333 @ $29.87EDGAR
2022-01-314Relay Therapeutics, Inc. (RLAY)Grant/award (A): 39,270 @ $0 · Grant/award (A): 78,540 (derivative) @ $0EDGAR
2022-01-074Relay Therapeutics, Inc. (RLAY)Grant/award (A): 658 @ $26.10EDGAR
2021-12-274Relay Therapeutics, Inc. (RLAY)Sale (S): 295 @ $33.10EDGAR
2021-11-164Relay Therapeutics, Inc. (RLAY)Option exercise (M): 6,500 @ $4.12 · Sale (S): 6,500 @ $35.42 · Option exercise (M): 6,500 (derivative) @ $0EDGAR
2021-09-274Relay Therapeutics, Inc. (RLAY)Sale (S): 293 @ $36.87EDGAR
2021-09-134Relay Therapeutics, Inc. (RLAY)Option exercise (M): 6,500 @ $4.12 · Sale (S): 6,500 @ $35.02 · Option exercise (M): 6,500 (derivative) @ $0EDGAR
2021-06-304Relay Therapeutics, Inc. (RLAY)Sale (S): 293 @ $35.81EDGAR
2021-06-094Relay Therapeutics, Inc. (RLAY)Option exercise (M): 6,500 @ $4.12 · Sale (S): 6,500 @ $35 · Option exercise (M): 6,500 (derivative) @ $0EDGAR
2021-04-284Relay Therapeutics, Inc. (RLAY)Option exercise (M): 6,500 @ $4.12 · Sale (S): 6,500 @ $35 · Option exercise (M): 6,500 (derivative) @ $0EDGAR
2021-03-264Relay Therapeutics, Inc. (RLAY)Grant/award (A): 15,870 @ $0 · Grant/award (A): 31,740 (derivative) @ $0EDGAR
2021-01-294Relay Therapeutics, Inc. (RLAY)Option exercise (M): 5,000 @ $4.12 · Sale (S): 5,000 @ $55.05 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2020-12-154Relay Therapeutics, Inc. (RLAY)Grant/award (A): 67,588 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1636994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs